S. Sakaguchi, Regulatory T Cells, Cell, vol.101, issue.5, pp.455-458, 2000.
DOI : 10.1016/S0092-8674(00)80856-9
URL : https://hal.archives-ouvertes.fr/hal-01358192

R. Duchmann, E. Schmitt, P. Knolle, M. Zum-buschenfelde, K. Neurath et al., Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12, European Journal of Immunology, vol.1, issue.4, pp.934-938, 1996.
DOI : 10.1002/eji.1830260432

S. Rakoff-nahoum, J. Paglino, F. Eslami-varzaneh, S. Edberg, and R. Medzhitov, Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis, Cell, vol.118, issue.2, pp.229-241, 2004.
DOI : 10.1016/j.cell.2004.07.002

A. Neish, A. Gewirtz, H. Zeng, A. Young, and M. Hobert, Prokaryotic Regulation of Epithelial Responses by Inhibition of Ikappa B-alpha Ubiquitination, Science, vol.289, issue.5484, pp.1560-1563, 2000.
DOI : 10.1126/science.289.5484.1560

D. Kelly, J. Campbell, T. King, G. Grant, and E. Jansson, Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-?? and RelA, Nature Immunology, vol.5, issue.1, pp.104-112, 2004.
DOI : 10.1038/ni1018

K. Madsen, J. Doyle, D. Jewell, M. Tavernini, and N. Fedorak, Lactobacillus species prevents colitis in interleukin 10 gene???deficient mice, Gastroenterology, vol.116, issue.5, pp.1107-1114, 1999.
DOI : 10.1016/S0016-5085(99)70013-2

R. Sartor, Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics, Gastroenterology, vol.126, issue.6, pp.1620-1633, 2004.
DOI : 10.1053/j.gastro.2004.03.024

K. Lammers, A. Vergopoulos, N. Babel, P. Gionchetti, and F. Rizzello, Probiotic Therapy in the Prevention of Pouchitis Onset: Decreased Interleukin-1??, Interleukin-8, and Interferon-?? Gene Expression, Inflammatory Bowel Diseases, vol.11, issue.5, pp.447-454, 2005.
DOI : 10.1097/01.mpa.0000160302.40931.7b

R. Bibiloni, R. Fedorak, G. Tannock, K. Madsen, and P. Gionchetti, VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis, The American Journal of Gastroenterology, vol.122, issue.4, pp.1539-1546, 2005.
DOI : 10.1078/072320203322346128

H. Christensen, H. Frokiaer, and J. Pestka, Lactobacilli Differentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells, The Journal of Immunology, vol.168, issue.1, pp.171-178, 2002.
DOI : 10.4049/jimmunol.168.1.171

A. Hart, K. Lammers, P. Brigidi, B. Vitali, and F. Rizzello, Modulation of human dendritic cell phenotype and function by probiotic bacteria, Gut, vol.53, issue.11, pp.1602-1609, 2004.
DOI : 10.1136/gut.2003.037325

B. Sheil, J. Mccarthy, L. Mahony, M. Bennett, and P. Ryan, Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis, Gut, vol.53, issue.5, pp.694-700, 2004.
DOI : 10.1136/gut.2003.027789

B. Foligne, C. Grangette, and B. Pot, Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects, Gut, vol.54, pp.727-728, 2005.

H. Smits, A. Engering, D. Van-der-kleij, E. De-jong, and K. Schipper, Selective probiotic bacteria induce IL-10???producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell???specific intercellular adhesion molecule 3???grabbing nonintegrin, Journal of Allergy and Clinical Immunology, vol.115, issue.6, pp.1260-1267, 2005.
DOI : 10.1016/j.jaci.2005.03.036

P. Tan, P. Sagoo, C. Chan, J. Yates, and J. Campbell, Inhibition of NF-??B and Oxidative Pathways in Human Dendritic Cells by Antioxidative Vitamins Generates Regulatory T Cells, The Journal of Immunology, vol.174, issue.12, pp.7633-7644, 2005.
DOI : 10.4049/jimmunol.174.12.7633

M. Zhu, M. Wei, F. Liu, H. Shi, and G. Wang, Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival, World J Gastroenterol, vol.9, pp.2509-2512, 2003.
DOI : 10.1016/j.transproceed.2004.08.034

U. Grohmann, F. Fallarino, and P. Puccetti, Tolerance, DCs and tryptophan: much ado about IDO, Trends in Immunology, vol.24, issue.5, pp.242-248, 2003.
DOI : 10.1016/S1471-4906(03)00072-3

A. Mellor and D. Munn, Ido expression by dendritic cells: tolerance and tryptophan catabolism, Nature Reviews Immunology, vol.467, issue.10, pp.762-774, 2004.
DOI : 10.1016/S0041-1345(00)02792-5

A. Wolf, D. Wolf, H. Rumpold, A. Moschen, and A. Kaser, Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease, Clinical Immunology, vol.113, issue.1, pp.47-55, 2004.
DOI : 10.1016/j.clim.2004.05.004

S. Corinti, D. Medaglini, A. Cavani, M. Rescigno, and G. Pozzi, Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes, J Immunol, vol.163, pp.3029-3036, 1999.

G. Oldenhove, M. De-heusch, G. Urbain-vansanten, U. J. Maliszewski, and C. , Regulatory T Cells Control T Helper Cell Type 1 Responses to Foreign Antigens Induced by Mature Dendritic Cells In Vivo, The Journal of Experimental Medicine, vol.160, issue.2, pp.259-266, 2003.
DOI : 10.1084/jem.20030012

S. Zelenay and J. Demengeot, Comment on "Cutting Edge: Anti-CD25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4+CD25+ T Regulatory Cells", The Journal of Immunology, vol.177, issue.4, pp.2036-2037, 2006.
DOI : 10.4049/jimmunol.177.4.2036-a

L. Stephens and S. Anderton, Comment onCutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells, J Immunol, vol.177, pp.2037-2045, 2006.

T. Kaisho and S. Akira, Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice, Trends in Immunology, vol.22, issue.2, pp.8-83, 2001.
DOI : 10.1016/S1471-4906(00)01811-1

C. Elson, K. Beagley, A. Sharmanov, K. Fujihashi, and H. Kiyono, Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance, J Immunol, vol.157, pp.2174-2185, 1996.

C. Mottet, H. Uhlig, and F. Powrie, Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells, The Journal of Immunology, vol.170, issue.8, pp.3939-3943, 2003.
DOI : 10.4049/jimmunol.170.8.3939

C. Grangette, S. Nutten, E. Palumbo, S. Morath, and C. Hermann, From The Cover: Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids, Proceedings of the National Academy of Sciences, vol.102, issue.29, pp.10321-10326, 2005.
DOI : 10.1073/pnas.0504084102

D. Giacinto, C. Marinaro, M. Sanchez, M. Strober, W. Boirivant et al., Probiotics Ameliorate Recurrent Th1-Mediated Murine Colitis by Inducing IL-10 and IL-10-Dependent TGF-??-Bearing Regulatory Cells, The Journal of Immunology, vol.174, issue.6, pp.3237-3283, 2005.
DOI : 10.4049/jimmunol.174.6.3237

H. Braat, J. Van-den-brande, E. Van-tol, D. Hommes, and M. Peppelenbosch, Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function, Am J Clin Nutr, vol.80, pp.1618-1625, 2004.

T. Velde, A. Verstege, M. Hommes, and D. , Critical appraisal of the current practice in murine TNBS-induced colitis, Inflammatory Bowel Diseases, vol.12, issue.10, pp.995-999, 2006.
DOI : 10.1097/01.mib.0000227817.54969.5e

K. Vandenbroucke, W. Hans, J. Van-huysse, S. Neirynck, and P. Demetter, Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice, Gastroenterology, vol.127, issue.2, pp.502-513, 2004.
DOI : 10.1053/j.gastro.2004.05.020

T. Nishihara, M. Matsuda, H. Araki, K. Oshima, and S. Kihara, Effect of Adiponectin on Murine Colitis Induced by Dextran Sulfate Sodium, Gastroenterology, vol.131, issue.3, pp.853-861, 2006.
DOI : 10.1053/j.gastro.2006.06.015

E. Hollenbach, M. Vieth, A. Roessner, M. Neumann, and P. Malfertheiner, Inhibition of RICK/Nuclear Factor-??B and p38 Signaling Attenuates the Inflammatory Response in a Murine Model of Crohn Disease, Journal of Biological Chemistry, vol.280, issue.15, pp.14981-14988, 2005.
DOI : 10.1074/jbc.M500966200

B. Mckenzie, R. Kastelein, and D. Cua, Understanding the IL-23???IL-17 immune pathway, Trends in Immunology, vol.27, issue.1, pp.17-23, 2006.
DOI : 10.1016/j.it.2005.10.003

S. Fiorucci, J. Wallace, A. Mencarelli, E. Distrutti, and G. Rizzo, A ??-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction, Proceedings of the National Academy of Sciences, vol.101, issue.44, pp.15736-15741, 2004.
DOI : 10.1073/pnas.0404722101
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC524215

Y. Cong, A. Konrad, N. Iqbal, R. Hatton, and C. Weaver, Generation of Antigen-Specific, Foxp3-Expressing CD4+ Regulatory T Cells by Inhibition of APC Proteosome Function, The Journal of Immunology, vol.174, issue.5, pp.2787-2795, 2005.
DOI : 10.4049/jimmunol.174.5.2787

D. Rachmilewitz, K. Katakura, F. Karmeli, T. Hayashi, and C. Reinus, Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis, Gastroenterology, vol.126, issue.2, pp.520-528, 2004.
DOI : 10.1053/j.gastro.2003.11.019

J. Hugot, M. Chamaillard, H. Zouali, S. Lesage, and J. Cezard, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, Nature, vol.411, issue.6837, pp.599-603, 2001.
DOI : 10.1038/35079107

H. Torok, J. Glas, L. Tonenchi, G. Bruennler, and M. Folwaczny, Crohn???s disease is associated with a toll-like receptor-9 polymorphism, Gastroenterology, vol.127, issue.1, pp.365-366, 2004.
DOI : 10.1053/j.gastro.2004.05.051

T. Watanabe, A. Kitani, P. Murray, and W. Strober, NOD2 is a negative regulator of Toll-like receptor 2???mediated T helper type 1 responses, Nature Immunology, vol.52, issue.8, pp.800-808, 2004.
DOI : 10.1016/S0006-291X(02)02807-3

D. Van-heel, S. Ghosh, K. Hunt, C. Mathew, and A. Forbes, Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease, Gut, vol.54, issue.11, pp.1553-1557, 2005.
DOI : 10.1136/gut.2005.065888

L. Travassos, S. Girardin, D. Philpott, D. Blanot, and M. Nahori, Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition, EMBO reports, vol.5, issue.10, pp.1000-1006, 2004.
DOI : 10.1038/sj.embor.7400248
URL : https://hal.archives-ouvertes.fr/pasteur-00139190

H. Hackstein and A. Thomson, Dendritic cells: emerging pharmacological targets of immunosuppressive drugs, Nature Reviews Immunology, vol.4, issue.1, pp.24-34, 2004.
DOI : 10.1038/nri1256

M. Lutz, N. Kukutsch, A. Ogilvie, S. Rossner, and F. Koch, An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow, Journal of Immunological Methods, vol.223, issue.1, pp.77-92, 1999.
DOI : 10.1016/S0022-1759(98)00204-X

O. Takeuchi, K. Hoshino, T. Kawai, H. Sanjo, and H. Takada, Differential Roles of TLR2 and TLR4 in Recognition of Gram-Negative and Gram-Positive Bacterial Cell Wall Components, Immunity, vol.11, issue.4, pp.443-451, 1999.
DOI : 10.1016/S1074-7613(00)80119-3

C. Noel, D. Gerbod, P. Delgado-viscogliosi, N. Fast, and A. Younes, Morphogenesis during division and griseofulvin-induced changes of the microtubular cytoskeleton in the parasitic protist, Trichomonas vaginalis, Parasitol Res, vol.89, pp.487-494, 2003.

B. Foligne, S. Nutten, L. Steidler, V. Dennin, and D. Goudercourt, Recommendations for Improved Use of the Murine TNBS-Induced Colitis Model in Evaluating Anti-inflammatory Properties of Lactic Acid Bacteria: Technical and Microbiological Aspects, Digestive Diseases and Sciences, vol.133, issue.2, pp.394-404, 2006.
DOI : 10.1007/s10620-006-3143-x

J. Wallace, W. Macnaughton, G. Morris, and P. Beck, Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease, Gastroenterology, vol.96, issue.1, pp.29-36, 1989.
DOI : 10.1016/0016-5085(89)90760-9

P. Bradley, D. Priebat, R. Christensen, and G. Rothstein, Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme Marker, Journal of Investigative Dermatology, vol.78, issue.3, pp.206-209, 1982.
DOI : 10.1111/1523-1747.ep12506462

J. Lowenthal, P. Corthesy, C. Tougne, R. Lees, and H. Macdonald, High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61, J Immunol, vol.135, pp.3988-3994, 1985.

M. Gasson, Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing, J Bacteriol, vol.154, pp.1-9, 1983.

J. Sambrook, E. Fritsch, and T. Maniatis, Molecular cloning: a laboratory manual. Cold Spring Harbor, 1989.